These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 29735900)

  • 21. Fluorinated pyridinium oximes as potential reactivators for acetylcholinesterases inhibited by paraoxon organophosphorus agent.
    Jeong HC; Park NJ; Chae CH; Musilek K; Kassa J; Kuca K; Jung YS
    Bioorg Med Chem; 2009 Sep; 17(17):6213-7. PubMed ID: 19665386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-exposure treatment with the oxime RS194B rapidly reactivates and reverses advanced symptoms of lethal inhaled paraoxon in macaques.
    Rosenberg YJ; Wang J; Ooms T; Rajendran N; Mao L; Jiang X; Lees J; Urban L; Momper JD; Sepulveda Y; Shyong YJ; Taylor P
    Toxicol Lett; 2018 Sep; 293():229-234. PubMed ID: 29129799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel tacrine-pyridinium hybrid reactivators of organophosphorus-inhibited acetylcholinesterase: Synthesis, molecular docking, and in vitro reactivation study.
    Kim J; Malpani YR; Lee J; Shin JS; Han SB; Jung YS
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3784-3786. PubMed ID: 30301674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the potency of the oxime HLö-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
    Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
    Acta Medica (Hradec Kralove); 2005; 48(2):81-6. PubMed ID: 16259317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bisquaternary pyridinium oximes: Comparison of in vitro reactivation potency of compounds bearing aliphatic linkers and heteroaromatic linkers for paraoxon-inhibited electric eel and recombinant human acetylcholinesterase.
    Bharate SB; Guo L; Reeves TE; Cerasoli DM; Thompson CM
    Bioorg Med Chem; 2010 Jan; 18(2):787-94. PubMed ID: 20005727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudo-catalytic scavenging: searching for a suitable reactivator of phosphorylated butyrylcholinesterase.
    Kovarik Z; Katalinić M; Sinko G; Binder J; Holas O; Jung YS; Musilova L; Jun D; Kuca K
    Chem Biol Interact; 2010 Sep; 187(1-3):167-71. PubMed ID: 20206154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structures of paraoxon-inhibited human acetylcholinesterase reveal perturbations of the acyl loop and the dimer interface.
    Franklin MC; Rudolph MJ; Ginter C; Cassidy MS; Cheung J
    Proteins; 2016 Sep; 84(9):1246-56. PubMed ID: 27191504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon.
    Petroianu GA; Arafat K; Kuca K; Kassa J
    J Appl Toxicol; 2006; 26(1):64-71. PubMed ID: 16193529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monooxime Bispyridinium Reactivators Bearing Xylene Linker Synthesis and In Vitro Evaluation on Model of Organophosphate-Inhibited Acetylcholinesterase.
    Musilek K; Hambalek J; Holas O; Dohnal V; Kuca K
    Med Chem; 2016; 12(4):362-70. PubMed ID: 26427931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactivating potency of obidoxime, pralidoxime, HI 6 and HLö 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds.
    Worek F; Widmann R; Knopff O; Szinicz L
    Arch Toxicol; 1998 Mar; 72(4):237-43. PubMed ID: 9587020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Syntheses and in vitro evaluations of uncharged reactivators for human acetylcholinesterase inhibited by organophosphorus nerve agents.
    Renou J; Mercey G; Verdelet T; Păunescu E; Gillon E; Arboléas M; Loiodice M; Kliachyna M; Baati R; Nachon F; Jean L; Renard PY
    Chem Biol Interact; 2013 Mar; 203(1):81-4. PubMed ID: 23111374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in silico Evaluation of Non-Quaternary Reactivators of AChE as Antidotes of Organophosphorus Poisoning - a New Hope or a Blind Alley?
    Soukup O; Korabecny J; Malinak D; Nepovimova E; Pham NL; Musilek K; Hrabinova M; Hepnarova V; Dolezal R; Pavek P; Jost P; Kobrlova T; Jankockova J; Gorecki L; Psotka M; Nguyen TD; Box K; Outhwaite B; Ceckova M; Sorf A; Jun D; Kuca K
    Med Chem; 2018; 14(3):281-292. PubMed ID: 29332594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning.
    Antonijevic B; Stojiljkovic MP
    Clin Med Res; 2007 Mar; 5(1):71-82. PubMed ID: 17456837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents.
    Mercey G; Verdelet T; Renou J; Kliachyna M; Baati R; Nachon F; Jean L; Renard PY
    Acc Chem Res; 2012 May; 45(5):756-66. PubMed ID: 22360473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro potency of H oximes (HI-6, HLö-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase.
    Kuca K; Cabal J; Kassa J; Jun D; Hrabinova M
    J Toxicol Environ Health A; 2006 Aug; 69(15):1431-40. PubMed ID: 16766478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New oxime reactivators connected with CH2O(CH2)nOCH2 linker and their reactivation potency for organophosphorus agents-inhibited acetylcholinesterase.
    Yang GY; Oh KA; Park NJ; Jung YS
    Bioorg Med Chem; 2007 Dec; 15(24):7704-10. PubMed ID: 17869525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the reactivation rates of acetylcholinesterase modified by structurally different organophosphates using novel pyridinium oximes.
    Bharate SB; Chao CK; Thompson CM
    Environ Toxicol Pharmacol; 2019 Oct; 71():103218. PubMed ID: 31302432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of human plasma on the reactivation of sarin-inhibited human erythrocyte acetylcholinesterase.
    Worek F; Eyer P; Kiderlen D; Thiermann H; Szinicz L
    Arch Toxicol; 2000 Mar; 74(1):21-6. PubMed ID: 10817663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
    Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
    Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactivation of human acetylcholinesterase and butyrylcholinesterase inhibited by leptophos-oxon with different oxime reactivators in vitro.
    Jun D; Musilova L; Pohanka M; Jung YS; Bostik P; Kuca K
    Int J Mol Sci; 2010 Aug; 11(8):2856-63. PubMed ID: 21152278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.